Use of Intravenous Albumin

作者：Jeannie Callum, Jeannie Callum, Nikolaos J. Skubas, Aarti Bathla, Homa Keshavarz, Edward G. Clark, Bram Rochwerg, Dean Fergusson, Sesmu Arbous, Seth R. Bauer, Louise China, Mark Fung, Rachel Jug, Michael Neill, Cary H. Paine, Katerina Pavenski, Prakesh S. Shah, Susan Robinson, Hua Shan, Zbigniew M. Szczepiorkowski, Thierry Thévenot, Bovey Wu, Simon Stanworth, Nadine Shehata, Jerome Flores, Stéfanie Frappier, Yvette Hou, Lilly Jean-Pierre, Danny Jomaa, Monisha Kabir, Leo Kadota, Michelle Lam, David A. Ripsman, Ryan Sandarage, Emiliyan Staykov, Angelica Venes, Melissa Wan, Arwa Al Riyami, Shubha Allard, Melissa Brouwers, Jeannie Callum, Jeannie Callum, James Daly, Gregory A. Denomme, Lise Estcourt, Dean Fergusson, Mark Fung, Laura Green, Andreas Greinacher, Heather Hume, Rachel Jug, Richard Kaufman, Hyungsuk Kim, Vernon Louw, Tadashi Matsushita, Michael Murphy, Joanne Pink, Susan Robinson, Cynthia So-Osman, Simon Stanworth, Zbigniew M. Szczepiorkowski, Aaron Tobian, Erica Wood · 发表于：CHEST Journal · 年份：2024 · DOI：10.1016/j.chest.2024.02.049 · 被引用次数：81 · 研究领域：Trauma, Hemostasis, Coagulopathy, Resuscitation、Acute Kidney Injury Research、Hemodynamic Monitoring and Therapy

BACKGROUND: Albumin is used commonly across a wide range of clinical settings to improve hemodynamics, to facilitate fluid removal, and to manage complications of cirrhosis. The International Collaboration for Transfusion Medicine Guidelines developed guidelines for the use of albumin in patients requiring critical care, undergoing cardiovascular surgery, undergoing kidney replacement therapy, or experiencing complications of cirrhosis. STUDY DESIGN AND METHODS: Cochairs oversaw the guideline development process and the panel included researchers, clinicians, methodologists, and a patient representative. The evidence informing this guideline arises from a systematic review of randomized clinical trials and systematic reviews, in which multiple databases were searched (inception through November 23, 2022). The panel reviewed the data and formulated the guideline recommendations using Grading of Recommendations Assessment, Development, and Evaluation methodology. The guidelines were revised after public consultation. RESULTS: The panel made 14 recommendations on albumin use in adult critical care (three recommendations), pediatric critical care (one recommendation), neonatal critical care (two recommendations), cardiovascular surgery (two recommendations), kidney replacement therapy (one recommendation), and complications of cirrhosis (five recommendations). Of the 14 recommendations, two recommendations had moderate certainty of evidence, five recommendations had low certainty...